Analysis of the latest market price trends of fostatinib (fotantinib) in 2025

Fostamatinib is an oral SYKtyrosine kinase inhibitor, mainly used to treat autoimmune diseases such as immune thrombocytopenia (ITP). As of2025, fostatinib has not been officially approved for marketing in mainland China, so domestic patients are temporarily unable to purchase the drug directly through formal channels. This current situation makes patients mainly rely on overseas markets to obtain drugs, and they face certain purchase and use difficulties.

In overseas markets, the original specification of fostatinib is generally 100mg*60 tablets per box, and the market price is about more than 20,000 yuan. This price reflects the higher R&D costs and market positioning of the original drug, which is a relatively expensive targeted therapy drug. Due to factors such as import channels, tariffs and transportation costs, overseas prices may fluctuate to a certain extent in different countries and regions, but overall they remain in a high price range.

As the global demand for the treatment of immune diseases increases, the fostatinib market attention is gradually increasing. It is expected that in the next few years, as more countries and regions approve the drug for marketing, market supply will gradually increase, and intensified competition may prompt price adjustments. In addition, as the research and development of biosimilars advances, the launch of generic versions in the future is expected to bring about a downward trend in prices and reduce the burden of medication on patients.

Although fostatinib is not currently on the market in China, it is expected to be introduced in the next few years as China's drug regulatory authorities accelerate the approval of innovative drugs. Patients should pay attention to the latest policy developments and plan treatment plans appropriately. When drugs cannot be obtained domestically, it is recommended to purchase them through regular overseas channels to avoid buying fake and shoddy products. At the same time, medication should be prescribed under the guidance of a doctor to ensure the safety and effectiveness of treatment.

Reference materials:https://www.drugs.com/